Sun Pharma Advanced Research Company submits press release

22 Aug 2019

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed about submission of the Press Release titled ‘SPARC to Provide Update on R&D Pipeline’, being released by the Company, which is self-explanatory. 

The above information is a part of company’s filings submitted to BSE.

Related Sun Pharma Advanced Research Company Ltd. Links:

Sun Pharma Adv. Res Share Price

170.55 0.90 (0.53%) Mar 08, 18:37
1 Year Price Chart
Peers
Company Name CMP
Quess Corp 726.70
SIS 422.20
TeamLease Services 3422.85
VA Tech Wabag 266.75
Syngene Internation. 537.45
View more..
Sensex vs Sun Pharma Adv. Res
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback